Global Proteomics Market: Analysis By Product, By Application, By Technology, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2027
Proteomics is the study of proteins involved in disease and their structure, function, and expression. It aids in understanding the process and interactions of an organism's entire protein content. Proteomic research also identifies prognostic markers and provides diagnostics for infectious diseases such as malaria and cancer. Proteomics is also used in the pharmaceutical industry to investigate the mechanism of drug action or toxicity, as well as to identify and validate the efficacy of biomarkers. In 2021, the global proteomics market was valued at US$24.98 billion, and is probable to reach US$95.29 billion by 2027.
Technical advancements, increased funding for research, rising healthcare costs, growing demand for tailored medication, and rising rates of genetic illnesses are also expected to drive market growth over the next coming years. The proteomics market is projected to grow at a CAGR of 25%, during the forecast period of 2022-2027.
Market Segmentation Analysis:
By Product: According to the report, the global proteomics market is segmented into three products: Reagents, Instruments and Services. Reagents segment acquired majority of share in the market in 2021, due to extensive use of reagents & consumables, kits, chemicals, and strips for the examination of various biological samples in academic institutions, research labs, and others, which will increase the demand for reagents & consumables fueling the segment growth. The same segment is expected to have the highest CAGR in the future due to technological developments of advanced instruments, such as 2-D electrophoresis protein analyzers.
By Application: According to the report, the global proteomics market is segmented into three applications: Drug discovery, Disease diagnosis and others. Drug discovery segment acquired majority of share in the market in 2021, due to the development of structure-based drug design, a greater emphasis on creating personalized drugs, and more investments in these areas can all be credited for the segment growth. Drug discovery segment is expected to have the highest CAGR in the future due to proteomics technologies also offer a way to show early on in a drug discovery program, saving pharmaceutical corporations a significant amount of capital and eventually benefiting patients as well as the healthcare systems.
By Technology: The report splits the global proteomics market into seven technology: X-Ray crystallography, Surface Plasmon Resonance, Protein Fractionation, Electrophoresis, Protein Microarrays, Spectroscopy and Chromatography. In 2021, Protein Microarrays segment held the maximum share in the market, because of high usage of this technology to track protein interactions in lesser time as compared to other technologies. Also, Protein Microarrays is predicted to have the highest CAGR in the future because this method is labor-intensive and cost-effective.
By End Users: The report splits the global proteomics market into five end users: Pharmaceutical companies, Hospitals, Clinical laboratories, Academic research laboratories and others. In 2021, Pharmaceutical companies segment held the maximum share in the market, due to the increasing investments in R&D that the companies have been making in the field of genomics and Proteomics. However, Academic research laboratories is predicted to have the highest CAGR in the future because of the increase in government support for clinical research projects.
By Region: According to this report, the global proteomics market can be divided into four major regions: North America (The US, Canada and Mexico), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), and Rest of the World. The North America proteomics market enjoyed the highest market share in 2021, primarily owing to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics.
While the US continues to be a prominent region of North America proteomics market, accounting to the rise in awareness and use of proteomics and technological advancements contribute majorly to the market growth of the region.
Global Proteomics Market Dynamics:
Growth Drivers: Increased investment in biotech companies in 2020 supported the development of the proteomics market. The pandemic has adversely affected most sectors, including healthcare. However, publicly traded biotech companies saw investment growth in March 2020 after the first indiscriminate shock in share prices. This is considered a positive indicator for the proteomics market. Further, the market is expected to increase due to rising prevalence of cancer and associated genetic disorder, faster turn–around times (tat), increased investments in R&D in the field of proteomics, accessibility and reproducibility, etc.
Challenges: Companies rely on publicly available structure data and trial-and-error methods to identify compounds that either stimulate or inhibit target proteins. Protein structure requires the use of fast, high throughput tools and machines. All of these procedures necessitate a large number of laboratory hours, which raises the per-sample testing costs. Other challenges that proteomics market face is dynamic range, PTMs explode the level of complexity in proteomics, high cost of instruments, etc.
Trends: A major trend gaining pace in proteomics market is artificial intelligence in proteomics. Artificial intelligence (AI) applications in proteomics are already reshaping the drug discovery landscape. Understanding how and why specific proteins interact is critical for progressing cell biology, developing new drugs, and determining how drugs may have both therapeutic and adverse effects. More trends in the market are believed to augment the growth of proteomics market during the forecasted period include surge in drug discovery, emerging method: high-plex proteomics, emerging technologies, increasing prominence of nanoproteomics and new applications based on proteomics technology advancements, etc.
Impact Analysis of COVID-19 and Way Forward:
Due to the COVID-19 pandemic, some clinical studies were temporarily delayed around the world. The pandemic created a lot of demand for proteomics services, which has had a big impact on the market. There is continued interest in using advanced mass spectrometers to improve quality outcomes for patients. In 2020, new technologies in mass spectrometers allowed the identification of proteins unique to COVID-19. The proteomics industry had seen positive growth during the pandemic.
Competitive Landscape and Recent Developments:
The proteomics market is concentrated with the presence of a few number of players majorly dominating worldwide. Key players of the proteomics market are:
Technical advancements, increased funding for research, rising healthcare costs, growing demand for tailored medication, and rising rates of genetic illnesses are also expected to drive market growth over the next coming years. The proteomics market is projected to grow at a CAGR of 25%, during the forecast period of 2022-2027.
Market Segmentation Analysis:
By Product: According to the report, the global proteomics market is segmented into three products: Reagents, Instruments and Services. Reagents segment acquired majority of share in the market in 2021, due to extensive use of reagents & consumables, kits, chemicals, and strips for the examination of various biological samples in academic institutions, research labs, and others, which will increase the demand for reagents & consumables fueling the segment growth. The same segment is expected to have the highest CAGR in the future due to technological developments of advanced instruments, such as 2-D electrophoresis protein analyzers.
By Application: According to the report, the global proteomics market is segmented into three applications: Drug discovery, Disease diagnosis and others. Drug discovery segment acquired majority of share in the market in 2021, due to the development of structure-based drug design, a greater emphasis on creating personalized drugs, and more investments in these areas can all be credited for the segment growth. Drug discovery segment is expected to have the highest CAGR in the future due to proteomics technologies also offer a way to show early on in a drug discovery program, saving pharmaceutical corporations a significant amount of capital and eventually benefiting patients as well as the healthcare systems.
By Technology: The report splits the global proteomics market into seven technology: X-Ray crystallography, Surface Plasmon Resonance, Protein Fractionation, Electrophoresis, Protein Microarrays, Spectroscopy and Chromatography. In 2021, Protein Microarrays segment held the maximum share in the market, because of high usage of this technology to track protein interactions in lesser time as compared to other technologies. Also, Protein Microarrays is predicted to have the highest CAGR in the future because this method is labor-intensive and cost-effective.
By End Users: The report splits the global proteomics market into five end users: Pharmaceutical companies, Hospitals, Clinical laboratories, Academic research laboratories and others. In 2021, Pharmaceutical companies segment held the maximum share in the market, due to the increasing investments in R&D that the companies have been making in the field of genomics and Proteomics. However, Academic research laboratories is predicted to have the highest CAGR in the future because of the increase in government support for clinical research projects.
By Region: According to this report, the global proteomics market can be divided into four major regions: North America (The US, Canada and Mexico), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), and Rest of the World. The North America proteomics market enjoyed the highest market share in 2021, primarily owing to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics.
While the US continues to be a prominent region of North America proteomics market, accounting to the rise in awareness and use of proteomics and technological advancements contribute majorly to the market growth of the region.
Global Proteomics Market Dynamics:
Growth Drivers: Increased investment in biotech companies in 2020 supported the development of the proteomics market. The pandemic has adversely affected most sectors, including healthcare. However, publicly traded biotech companies saw investment growth in March 2020 after the first indiscriminate shock in share prices. This is considered a positive indicator for the proteomics market. Further, the market is expected to increase due to rising prevalence of cancer and associated genetic disorder, faster turn–around times (tat), increased investments in R&D in the field of proteomics, accessibility and reproducibility, etc.
Challenges: Companies rely on publicly available structure data and trial-and-error methods to identify compounds that either stimulate or inhibit target proteins. Protein structure requires the use of fast, high throughput tools and machines. All of these procedures necessitate a large number of laboratory hours, which raises the per-sample testing costs. Other challenges that proteomics market face is dynamic range, PTMs explode the level of complexity in proteomics, high cost of instruments, etc.
Trends: A major trend gaining pace in proteomics market is artificial intelligence in proteomics. Artificial intelligence (AI) applications in proteomics are already reshaping the drug discovery landscape. Understanding how and why specific proteins interact is critical for progressing cell biology, developing new drugs, and determining how drugs may have both therapeutic and adverse effects. More trends in the market are believed to augment the growth of proteomics market during the forecasted period include surge in drug discovery, emerging method: high-plex proteomics, emerging technologies, increasing prominence of nanoproteomics and new applications based on proteomics technology advancements, etc.
Impact Analysis of COVID-19 and Way Forward:
Due to the COVID-19 pandemic, some clinical studies were temporarily delayed around the world. The pandemic created a lot of demand for proteomics services, which has had a big impact on the market. There is continued interest in using advanced mass spectrometers to improve quality outcomes for patients. In 2020, new technologies in mass spectrometers allowed the identification of proteins unique to COVID-19. The proteomics industry had seen positive growth during the pandemic.
Competitive Landscape and Recent Developments:
The proteomics market is concentrated with the presence of a few number of players majorly dominating worldwide. Key players of the proteomics market are:
- Danaher Corporation
- Agilent Technologies
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Bruker Corporation
- Illumina Inc.
- Horiba, Ltd.
- Waters Corporation
- DiaSorin SpA (Luminex Corporation)
- Promega Corporation
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Proteomics: An Overview
2.1.1 Proteomics Overview
2.1.2 Characteristics of Existing Proteomics Technologies
2.2 Proteomics Segmentation: An Overview
2.2.1 Proteomics Segmentation
3. GLOBAL MARKET ANALYSIS
3.1 Global Proteomics Market: An Analysis
3.1.1 Global Proteomics Market: An Overview
3.1.2 Global Proteomics Market by Value
3.1.3 Global Proteomics Market by Product (Reagents, Instruments and Services)
3.1.4 Global Proteomics Market by Application (Drug discovery, Disease diagnosis and others)
3.1.5 Global Proteomics Market by Technology (X-Ray crystallography, Surface Plasmon Resonance, Protein Fractionation, Electrophoresis, Protein Microarrays, Spectroscopy and Chromatography)
3.1.6 Global Proteomics Market by End Users (Pharmaceutical companies, Hospitals, Clinical laboratories, Academic research laboratories and others)
3.1.7 Global Proteomics Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Proteomics Market: Product Analysis
3.2.1 Global Proteomics Market by Product: An Overview
3.2.2 Global Reagents Proteomics Market by Value
3.2.3 Global Instruments Proteomics Market by Value
3.2.4 Global Services Proteomics Market by Value
3.3 Global Proteomics Market: Application Analysis
3.3.1 Global Proteomics Market by Application: An Overview
3.3.2 Global Drug Discovery Proteomics Market by Value
3.3.3 Global Disease Diagnosis Proteomics Market by Value
3.3.4 Global Other Application Proteomics Market by Value
3.4 Global Proteomics Market: Technology Analysis
3.4.1 Global Proteomics Market by Technology: An Overview
3.4.2 Global X-Ray Crystallography Proteomics Market by Value
3.4.3 Global Surface Plasmon Resonance Proteomics Market by Value
3.4.4 Global Protein Fractionation Proteomics Market by Value
3.4.5 Global Electrophoresis Proteomics Market by Value
3.4.6 Global Protein Microarrays Proteomics Market by Value
3.4.7 Global Spectroscopy Proteomics Market by Value
3.4.8 Global Chromatography Proteomics Market by Value
3.5 Global Proteomics Market: End Users Analysis
3.5.1 Global Proteomics Market by End Users: An Overview
3.5.2 Global Hospitals Proteomics Market by Value
3.5.3 Global Clinical Laboratories Proteomics Market by Value
3.5.4 Global Pharmaceutical Companies Proteomics Market by Value
3.5.5 Global Academic Research Laboratories Proteomics Market by Value
3.5.6 Global Other End Users Proteomics Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 North America Proteomics Market: An Analysis
4.1.1 North America Proteomics Market: An Overview
4.1.2 North America Proteomics Market by Value
4.1.3 North America Proteomics Market by Region (The US, Canada and Mexico)
4.1.4 The US Proteomics Market by Value
4.1.5 The US Proteomics Market by Application (Drug discovery, Disease diagnosis and others)
4.1.6 The US Drug Discovery Proteomics Market by Value
4.1.7 The US Disease Diagnosis Proteomics Market by Value
4.1.8 The US Other Proteomics Market by Value
4.1.9 Canada Proteomics Market by Value
4.1.10 Mexico Proteomics Market by Value
4.2 Europe Proteomics Market: An Analysis
4.2.1 Europe Proteomics Market: An Overview
4.2.2 Europe Proteomics Market by Value
4.2.3 Europe Proteomics Market by Region (Germany, France, UK, Italy, Spain and Rest of Europe)
4.2.4 UK Proteomics Market by Value
4.2.5 Germany Proteomics Market by Value
4.2.6 France Proteomics Market by Value
4.2.7 Italy Proteomics Market by Value
4.2.8 Spain Proteomics Market by Value
4.2.9 Rest of Europe Proteomics Market by Value
4.3 Asia Pacific Proteomics Market: An Analysis
4.3.1 Asia Pacific Proteomics Market: An Overview
4.3.2 Asia Pacific Proteomics Market by Value
4.3.3 Asia Pacific Proteomics Market by Region (China, Japan, India, and Rest of Asia Pacific)
4.3.4 China Proteomics Market by Value
4.3.5 Japan Proteomics Market by Value
4.3.6 India Proteomics Market by Value
4.3.7 Rest of Asia Pacific Proteomics Market by Value
4.4 Rest of the World Proteomics Market: An Analysis
4.4.1 Rest of the World Proteomics Market: An Overview
4.4.2 Rest of the World Proteomics Market by Value
5. IMPACT OF COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Proteomics Market
5.1.2 Post COVID-19 Impact
6. MARKET DYNAMICS
6.1 Growth Driver
6.1.1 Rising Prevalence of Cancer and Associated Genetic Disorder
6.1.2 Faster Turn–around Times (TAT)
6.1.3 Growth in Investments in Biotech Companies
6.1.4 Increased Investments in R&D in the Field of Proteomics
6.1.5 Accessibility and Reproducibility
6.2 Challenges
6.2.1 Dynamic Range
6.2.2 High Cost of Instruments
6.2.3 PTMs Explode the Level of Complexity in Proteomics
6.3 Market Trends
6.3.1 Artificial Intelligence in Proteomics
6.3.2 Surge in Drug Discovery
6.3.3 Emerging Method: High-Plex Proteomics
6.3.4 Emerging Technologies
6.3.5 Increasing Prominence Of Nanoprteomics
6.3.6 New Applications Based On Proteomics Technology Advancements
7. COMPETITIVE LANDSCAPE
7.1 Global Proteomics Market Players: Technology Comparison
8. COMPANY PROFILES
8.1 Danaher Corporation
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Agilent Technologies
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 PerkinElmer, Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Bio-rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Thermo Fisher Scientific Inc.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Bruker Corporation
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Illumina Inc.
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 Horiba, Ltd.
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Waters Corporation
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 DiaSorin SpA (Luminex Corporation)
8.10.1 Business Overview
8.10.2 Revenue by Technology
8.10.3 Business Strategy
8.11 Promega Corporation
8.11.1 Business Overview
8.11.2 Business Strategy
12. LIST OF FIGURES
Figure 1: Proteomics Segmentation
Figure 2: Global Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 3: Global Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 4: Global Proteomics Market by Product; 2021 (Percentage, %)
Figure 5: Global Proteomics Market by Application; 2021 (Percentage, %)
Figure 6: Global Proteomics Market by Technology; 2021 (Percentage, %)
Figure 7: Global Proteomics Market by End Users; 2021 (Percentage, %)
Figure 8: Global Proteomics Market by Region; 2021 (Percentage, %)
Figure 9: Global Reagents Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 10: Global Reagents Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 11: Global Instruments Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 12: Global Instruments Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 13: Global Services Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 14: Global Services Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 15: Global Drug Discovery Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 16: Global Drug Discovery Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 17: Global Disease Diagnosis Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 18: Global Disease Diagnosis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 19: Global Other Application Proteomics Market by Value; 2017-2017 (US$ Billion)
Figure 20: Global Other Application Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 21: Global X-Ray Crystallography Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 22: Global X-Ray Crystallography Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 23: Global Surface Plasmon Resonance Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 24: Global Surface Plasmon Resonance Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 25: Global Protein Fractionation Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 26: Global Protein Fractionation Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 27: Global Electrophoresis Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 28: Global Electrophoresis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 29: Global Protein Microarrays Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 30: Global Protein Microarrays Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 31: Global Spectroscopy Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 32: Global Spectroscopy Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 33: Global Chromatography Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 34: Global Chromatography Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 35: Global Hospitals Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 36: Global Hospitals Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 37: Global Clinical Laboratories Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 38: Global Clinical Laboratories Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 39: Global Pharmaceutical Companies Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 40: Global Pharmaceutical Companies Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 41: Global Academic Research Laboratories Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 42: Global Academic Research Laboratories Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 43: Global Other End Users Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 44: Global Other End Users Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 45: North America Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 46: North America Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 47: North America Proteomics Market by Region; 2021 (Percentage, %)
Figure 48: The US Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 49: The US Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 50: The US Proteomics Market by Application; 2021 (Percentage, %)
Figure 51: The US Drug Discovery Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 52: The US Drug Discovery Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 53: The US Disease Diagnosis Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 54: The US Disease Diagnosis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 55: The US Other Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 56: The US Other Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 57: Canada Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 58: Canada Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 59: Mexico Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 60: Mexico Proteomics Market by Value; 2022-2027 (US$ Million)
Figure 61: Europe Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 62: Europe Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 63: Europe Proteomics Market by Region; 2021 (Percentage, %)
Figure 64: UK Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 65: UK Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 66: Germany Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 67: Germany Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 68: France Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 69: France Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 70: Italy Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 71: Italy Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 72: Spain Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 73: Spain Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 74: Rest of Europe Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 75: Rest of Europe Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 76: Asia Pacific Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 77: Asia Pacific Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 78: Asia Pacific Proteomics Market by Region; 2021 (Percentage, %)
Figure 79: China Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 80: China Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 81: Japan Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 82: Japan Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 83: India Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 84: India Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 85: Rest of Asia Pacific Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 86: Rest of Asia Pacific Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 87: Rest of the World Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 88: Rest of the World Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 89: Global Artificial Intelligence Market Revenue; 2020-2024 (US$ Billion)
Figure 90: Danaher Corporation Sales by Segment; 2021 (Percentage, %)
Figure 91: Agilent Technologies Net Revenue by Business Segment; 2021 (Percentage, %)
Figure 92: PerkinElmer, Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 93: Bio-rad Laboratories, Inc. Net Sales by Segment; 2021 (Percentage, %)
Figure 94: Thermo Fisher Scientific Inc. Revenues by Segment; 2021 (Percentage, %)
Figure 95: Bruker Corporation Revenue by Segment; 2021 (Percentage, %)
Figure 96: Illumina Inc. Revenues by Segment; 2022 (Percentage, %)
Figure 97: Horiba, Ltd. Net Sales by Segments; 2021 (Percentage, %)
Figure 98: Waters Corporation Net Sales by Segments; 2021 (Percentage, %)
Figure 99: DiaSorin SpA (Luminex Corporation) Revenue by Technology; 2021 (Parentage, %)
Table 1: Characteristics of Existing Proteomics Technologies
Table 2: High Plex Proteomic Comparison
Table 3: Global Proteomics Market Players: Technology Comparison
2. INTRODUCTION
2.1 Proteomics: An Overview
2.1.1 Proteomics Overview
2.1.2 Characteristics of Existing Proteomics Technologies
2.2 Proteomics Segmentation: An Overview
2.2.1 Proteomics Segmentation
3. GLOBAL MARKET ANALYSIS
3.1 Global Proteomics Market: An Analysis
3.1.1 Global Proteomics Market: An Overview
3.1.2 Global Proteomics Market by Value
3.1.3 Global Proteomics Market by Product (Reagents, Instruments and Services)
3.1.4 Global Proteomics Market by Application (Drug discovery, Disease diagnosis and others)
3.1.5 Global Proteomics Market by Technology (X-Ray crystallography, Surface Plasmon Resonance, Protein Fractionation, Electrophoresis, Protein Microarrays, Spectroscopy and Chromatography)
3.1.6 Global Proteomics Market by End Users (Pharmaceutical companies, Hospitals, Clinical laboratories, Academic research laboratories and others)
3.1.7 Global Proteomics Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Proteomics Market: Product Analysis
3.2.1 Global Proteomics Market by Product: An Overview
3.2.2 Global Reagents Proteomics Market by Value
3.2.3 Global Instruments Proteomics Market by Value
3.2.4 Global Services Proteomics Market by Value
3.3 Global Proteomics Market: Application Analysis
3.3.1 Global Proteomics Market by Application: An Overview
3.3.2 Global Drug Discovery Proteomics Market by Value
3.3.3 Global Disease Diagnosis Proteomics Market by Value
3.3.4 Global Other Application Proteomics Market by Value
3.4 Global Proteomics Market: Technology Analysis
3.4.1 Global Proteomics Market by Technology: An Overview
3.4.2 Global X-Ray Crystallography Proteomics Market by Value
3.4.3 Global Surface Plasmon Resonance Proteomics Market by Value
3.4.4 Global Protein Fractionation Proteomics Market by Value
3.4.5 Global Electrophoresis Proteomics Market by Value
3.4.6 Global Protein Microarrays Proteomics Market by Value
3.4.7 Global Spectroscopy Proteomics Market by Value
3.4.8 Global Chromatography Proteomics Market by Value
3.5 Global Proteomics Market: End Users Analysis
3.5.1 Global Proteomics Market by End Users: An Overview
3.5.2 Global Hospitals Proteomics Market by Value
3.5.3 Global Clinical Laboratories Proteomics Market by Value
3.5.4 Global Pharmaceutical Companies Proteomics Market by Value
3.5.5 Global Academic Research Laboratories Proteomics Market by Value
3.5.6 Global Other End Users Proteomics Market by Value
4. REGIONAL MARKET ANALYSIS
4.1 North America Proteomics Market: An Analysis
4.1.1 North America Proteomics Market: An Overview
4.1.2 North America Proteomics Market by Value
4.1.3 North America Proteomics Market by Region (The US, Canada and Mexico)
4.1.4 The US Proteomics Market by Value
4.1.5 The US Proteomics Market by Application (Drug discovery, Disease diagnosis and others)
4.1.6 The US Drug Discovery Proteomics Market by Value
4.1.7 The US Disease Diagnosis Proteomics Market by Value
4.1.8 The US Other Proteomics Market by Value
4.1.9 Canada Proteomics Market by Value
4.1.10 Mexico Proteomics Market by Value
4.2 Europe Proteomics Market: An Analysis
4.2.1 Europe Proteomics Market: An Overview
4.2.2 Europe Proteomics Market by Value
4.2.3 Europe Proteomics Market by Region (Germany, France, UK, Italy, Spain and Rest of Europe)
4.2.4 UK Proteomics Market by Value
4.2.5 Germany Proteomics Market by Value
4.2.6 France Proteomics Market by Value
4.2.7 Italy Proteomics Market by Value
4.2.8 Spain Proteomics Market by Value
4.2.9 Rest of Europe Proteomics Market by Value
4.3 Asia Pacific Proteomics Market: An Analysis
4.3.1 Asia Pacific Proteomics Market: An Overview
4.3.2 Asia Pacific Proteomics Market by Value
4.3.3 Asia Pacific Proteomics Market by Region (China, Japan, India, and Rest of Asia Pacific)
4.3.4 China Proteomics Market by Value
4.3.5 Japan Proteomics Market by Value
4.3.6 India Proteomics Market by Value
4.3.7 Rest of Asia Pacific Proteomics Market by Value
4.4 Rest of the World Proteomics Market: An Analysis
4.4.1 Rest of the World Proteomics Market: An Overview
4.4.2 Rest of the World Proteomics Market by Value
5. IMPACT OF COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Proteomics Market
5.1.2 Post COVID-19 Impact
6. MARKET DYNAMICS
6.1 Growth Driver
6.1.1 Rising Prevalence of Cancer and Associated Genetic Disorder
6.1.2 Faster Turn–around Times (TAT)
6.1.3 Growth in Investments in Biotech Companies
6.1.4 Increased Investments in R&D in the Field of Proteomics
6.1.5 Accessibility and Reproducibility
6.2 Challenges
6.2.1 Dynamic Range
6.2.2 High Cost of Instruments
6.2.3 PTMs Explode the Level of Complexity in Proteomics
6.3 Market Trends
6.3.1 Artificial Intelligence in Proteomics
6.3.2 Surge in Drug Discovery
6.3.3 Emerging Method: High-Plex Proteomics
6.3.4 Emerging Technologies
6.3.5 Increasing Prominence Of Nanoprteomics
6.3.6 New Applications Based On Proteomics Technology Advancements
7. COMPETITIVE LANDSCAPE
7.1 Global Proteomics Market Players: Technology Comparison
8. COMPANY PROFILES
8.1 Danaher Corporation
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Agilent Technologies
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 PerkinElmer, Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy
8.4 Bio-rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy
8.5 Thermo Fisher Scientific Inc.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Bruker Corporation
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Illumina Inc.
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 Horiba, Ltd.
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Waters Corporation
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 DiaSorin SpA (Luminex Corporation)
8.10.1 Business Overview
8.10.2 Revenue by Technology
8.10.3 Business Strategy
8.11 Promega Corporation
8.11.1 Business Overview
8.11.2 Business Strategy
12. LIST OF FIGURES
Figure 1: Proteomics Segmentation
Figure 2: Global Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 3: Global Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 4: Global Proteomics Market by Product; 2021 (Percentage, %)
Figure 5: Global Proteomics Market by Application; 2021 (Percentage, %)
Figure 6: Global Proteomics Market by Technology; 2021 (Percentage, %)
Figure 7: Global Proteomics Market by End Users; 2021 (Percentage, %)
Figure 8: Global Proteomics Market by Region; 2021 (Percentage, %)
Figure 9: Global Reagents Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 10: Global Reagents Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 11: Global Instruments Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 12: Global Instruments Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 13: Global Services Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 14: Global Services Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 15: Global Drug Discovery Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 16: Global Drug Discovery Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 17: Global Disease Diagnosis Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 18: Global Disease Diagnosis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 19: Global Other Application Proteomics Market by Value; 2017-2017 (US$ Billion)
Figure 20: Global Other Application Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 21: Global X-Ray Crystallography Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 22: Global X-Ray Crystallography Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 23: Global Surface Plasmon Resonance Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 24: Global Surface Plasmon Resonance Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 25: Global Protein Fractionation Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 26: Global Protein Fractionation Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 27: Global Electrophoresis Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 28: Global Electrophoresis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 29: Global Protein Microarrays Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 30: Global Protein Microarrays Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 31: Global Spectroscopy Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 32: Global Spectroscopy Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 33: Global Chromatography Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 34: Global Chromatography Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 35: Global Hospitals Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 36: Global Hospitals Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 37: Global Clinical Laboratories Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 38: Global Clinical Laboratories Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 39: Global Pharmaceutical Companies Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 40: Global Pharmaceutical Companies Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 41: Global Academic Research Laboratories Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 42: Global Academic Research Laboratories Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 43: Global Other End Users Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 44: Global Other End Users Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 45: North America Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 46: North America Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 47: North America Proteomics Market by Region; 2021 (Percentage, %)
Figure 48: The US Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 49: The US Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 50: The US Proteomics Market by Application; 2021 (Percentage, %)
Figure 51: The US Drug Discovery Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 52: The US Drug Discovery Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 53: The US Disease Diagnosis Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 54: The US Disease Diagnosis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 55: The US Other Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 56: The US Other Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 57: Canada Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 58: Canada Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 59: Mexico Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 60: Mexico Proteomics Market by Value; 2022-2027 (US$ Million)
Figure 61: Europe Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 62: Europe Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 63: Europe Proteomics Market by Region; 2021 (Percentage, %)
Figure 64: UK Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 65: UK Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 66: Germany Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 67: Germany Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 68: France Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 69: France Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 70: Italy Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 71: Italy Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 72: Spain Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 73: Spain Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 74: Rest of Europe Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 75: Rest of Europe Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 76: Asia Pacific Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 77: Asia Pacific Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 78: Asia Pacific Proteomics Market by Region; 2021 (Percentage, %)
Figure 79: China Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 80: China Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 81: Japan Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 82: Japan Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 83: India Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 84: India Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 85: Rest of Asia Pacific Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 86: Rest of Asia Pacific Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 87: Rest of the World Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 88: Rest of the World Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 89: Global Artificial Intelligence Market Revenue; 2020-2024 (US$ Billion)
Figure 90: Danaher Corporation Sales by Segment; 2021 (Percentage, %)
Figure 91: Agilent Technologies Net Revenue by Business Segment; 2021 (Percentage, %)
Figure 92: PerkinElmer, Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 93: Bio-rad Laboratories, Inc. Net Sales by Segment; 2021 (Percentage, %)
Figure 94: Thermo Fisher Scientific Inc. Revenues by Segment; 2021 (Percentage, %)
Figure 95: Bruker Corporation Revenue by Segment; 2021 (Percentage, %)
Figure 96: Illumina Inc. Revenues by Segment; 2022 (Percentage, %)
Figure 97: Horiba, Ltd. Net Sales by Segments; 2021 (Percentage, %)
Figure 98: Waters Corporation Net Sales by Segments; 2021 (Percentage, %)
Figure 99: DiaSorin SpA (Luminex Corporation) Revenue by Technology; 2021 (Parentage, %)
Table 1: Characteristics of Existing Proteomics Technologies
Table 2: High Plex Proteomic Comparison
Table 3: Global Proteomics Market Players: Technology Comparison
